IntelliPharmaCeutics Ltd., Vasogen deal

IntelliPharmaCeutics (IPC) will reverse-merge with Vasogen in a stock deal to create IntelliPharmaCeutics International Ltd. IPC's shareholders will own 86% of the combined company, and

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.